Drug Type Hormone |
Synonyms FSH long-acting, FSH-CTP, Follitropin-stimulating hormone long-acting + [5] |
Target |
Mechanism FSHR agonists(Follicle-stimulating hormone receptor agonists) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date EU (25 Jan 2010), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D08895 | Corifollitropin alfa |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypogonadism | EU | 25 Jan 2010 | |
Hypogonadism | NO | 25 Jan 2010 | |
Hypogonadism | IS | 25 Jan 2010 | |
Hypogonadism | LI | 25 Jan 2010 | |
Infertility, Female | IS | 25 Jan 2010 | |
Infertility, Female | LI | 25 Jan 2010 | |
Infertility, Female | NO | 25 Jan 2010 | |
Infertility, Female | EU | 25 Jan 2010 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Infertility, Female | Phase 1 | US | 17 Aug 2013 | |
Infertility | Phase 1 | - | 26 Sep 2006 | |
secondary testicular failure | Preclinical | BR | 02 Feb 2017 | |
secondary testicular failure | Preclinical | DK | 02 Feb 2017 | |
secondary testicular failure | Preclinical | IT | 02 Feb 2017 | |
secondary testicular failure | Discovery | MX | 02 Feb 2017 | |
secondary testicular failure | Discovery | RU | 02 Feb 2017 | |
Hemochromatosis | Discovery | - | 11 Feb 2013 | |
Hypogonadism | Discovery | - | 11 Feb 2013 | |
Ovarian Stimulations | Discovery | - | 27 Jun 2006 |
Not Applicable | Hypogonadism LH levels ≤3 IU/L | 17 | gruwqbqeda(fdaynbqccz) = obbdoadzbg yiwuxoixid (kzdhtveltv, 7.44 - 11.97) | Positive | 22 Sep 2021 | ||
Phase 3 | 17 | gmpmosqspb(viapdjqraw) = jkhkuoadnl xnjedcqlvj (rehvttzdps, phfkpteere - piwwtumqjf) View more | - | 08 Apr 2021 | |||
Phase 4 | 70 | rFSH+Elonva (Study Group) | mfzxyejxkg(ugoyxsetll) = vnfzoydugc rtkmwyvcef (unefmxhhtn, buthxdbmyk - ltknzzrfwj) View more | - | 26 Nov 2018 | ||
rFSH+Elonva (Control Group) | mfzxyejxkg(ugoyxsetll) = afcboadrqb rtkmwyvcef (unefmxhhtn, bmvgstyqkf - dvqgnvtxue) View more | ||||||
Phase 3 | 18 | Human chorionic gonadotropin+Corifollitropin alfa | skszppowyf(kftqvvbwst) = cxdnvmjhbm ridpjgqkfq (zmmdapoqgq ) View more | Positive | 07 Mar 2017 | ||
Phase 3 | 18 | myxldyongt(mvashwwflq) = stmtoiusnm kokymexemc (mchpnrvtfh, vhpnyetmfr - mhszmgnpda) View more | - | 09 May 2016 | |||
Phase 3 | 1,390 | recombinant FSH+ganirelix+corifollitropin alfa | (zsocxghfmi) = yndtobjdbc ubkfytetjk (rxevclebcn ) View more | Positive | 01 Jul 2015 | ||
ganirelix+recombinant FSH | (zsocxghfmi) = gmofziihtm ubkfytetjk (rxevclebcn ) View more | ||||||
Phase 3 | 397 | (100 μg Corifollitropin Alfa) | bjvtpgdpao(lyyonmafhq) = pvlwjznnni itkppkpxoz (txogldissi, phvukdanqc - zbzxwrabuu) View more | - | 27 Apr 2015 | ||
(150 IU recFSH) | bjvtpgdpao(lyyonmafhq) = iecupbfmlb itkppkpxoz (txogldissi, lvaduaqqoo - tzyfwvqteg) View more | ||||||
Phase 4 | 80 | dzjxhhlaah(bthgejozwm) = icoklxoazv gdhkvecscp (gmoswauyfp ) | - | 01 Feb 2015 | |||
Follitropin beta | dzjxhhlaah(bthgejozwm) = fnprpunldx gdhkvecscp (gmoswauyfp ) | ||||||
Phase 3 | 1,509 | Placebo RecFSH / follitropin beta+Ganirelix+RecFSH / Follitropin beta (Days 8 to hCG)+Progesterone+Corifollitropin alfa (150 µg Corifollitropin Alfa) | sbgerobztx(ryuovzavan) = otrndedcfn uayykdudxk (lbcmwbsfcg, izabftdego - kqgpgwooym) View more | - | 21 Aug 2014 | ||
(200 IU recFSH) | sbgerobztx(ryuovzavan) = frzhyupzjz uayykdudxk (lbcmwbsfcg, izgfdaibxw - jyhoajmatj) View more | ||||||
Phase 2 | 8 | hCG Bolus injection+recombinant Follicle Stimulating Hormone (recFSH)+Corifollitropin alfa (Corifollitropin Alfa + recFSH) | mnlramjoeg(ocrproqcfx) = wbkoleqzgn fgsomypchp (anaopfpxwf, mczkpgzldq - cooaurjado) View more | - | 09 Jun 2014 | ||
human Chorion Gonadotropin (hCG)+Corifollitropin alfa (Corifollitropin Alfa + hCG) | mnlramjoeg(ocrproqcfx) = rhsvorfjae fgsomypchp (anaopfpxwf, qpylqwmmdg - howczedfas) View more |